- Trials with a EudraCT protocol (7,377)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7,377 result(s) found.
Displaying page 1 of 369.
EudraCT Number: 2009-016877-14 | Sponsor Protocol Number: H1N1-2009 | Start Date*: 2009-11-04 |
Sponsor Name:COPSAC | ||
Full Title: H1N1v Vaccination of Pregnant Women: A Longitudinal Cohort Study Characterizing Influenza A-H1N1v Vaccination in Pregnant Women | ||
Medical condition: Protection against Influenza A H1N1v disease | ||
Disease: | ||
Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-010722-19 | Sponsor Protocol Number: BI71023_3001 | Start Date*: 2009-11-04 | |||||||||||
Sponsor Name:CSL Behring LLC | |||||||||||||
Full Title: A Prospective, Multicenter, Open-label, Phase 3b Study of Human Plasma-Derived Factor XIII Concentrate in Subjects with Congenital Factor XIII Deficiency Estudio prospectivo, multicéntrico, con et... | |||||||||||||
Medical condition: Congenital Factor XIII deficiency Deficiencia congénita de factor XIII | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022370-14 | Sponsor Protocol Number: 1015202 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Centre Hospitalier de Toulouse | |||||||||||||
Full Title: Evaluation de la tolérance d'une administration intra-nasale d'ocytocine chez des nourrissons présentant un syndrome de Prader-Willi et de son effet sur la succion et la prise alimentaire. | |||||||||||||
Medical condition: Syndrome de Prader Willi | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002342-21 | Sponsor Protocol Number: KB055 | Start Date*: 2014-07-29 |
Sponsor Name:Kedrion S.P.A | ||
Full Title: | ||
Medical condition: | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001189-40 | Sponsor Protocol Number: 3 | Start Date*: Information not available in EudraCT | ||||||||||||||||||||||||||
Sponsor Name:University of Tartu | ||||||||||||||||||||||||||||
Full Title: PHARMACOKINETICS OF ORAL SPIRONOLACTONE IN CHILDREN UP TO 2 YEARS OF AGE | ||||||||||||||||||||||||||||
Medical condition: cardiac failure, ascites and/or oedema | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: EE (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001024-31 | Sponsor Protocol Number: 08/S0501/31 | Start Date*: 2008-08-27 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: A randomised controlled trial of iodide supplementation in preterm infants with follow-up at 2 years | |||||||||||||
Medical condition: Transient hyothyroxinaemia | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005738-12 | Sponsor Protocol Number: LIPSTIC.V.01 | Start Date*: 2013-03-27 |
Sponsor Name:Alder Hey Children's NHS Foundation Trust | ||
Full Title: Liverpool Pharmacokinetic/pharmacodynamics study of teicoplanin in children (LIPSTIC). | ||
Medical condition: Gram-positive bacterial infection: late-onset neonatal sepsis, central line-associated blood stream infection, ventilator-associated pneumonia. | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002823-27 | Sponsor Protocol Number: GAVALAGG | Start Date*: 2016-11-17 | |||||||||||
Sponsor Name:INFECTOPHARM Arzneimittel GmbH | |||||||||||||
Full Title: Placebo-kontrollierte, multizentrische, randomisierte, doppelblinde Phase III-Studie zur Verbesserung der gastrointestinalen Verträglichkeit einer per-oralen Antibiotikatherapie durch add-on-Gabe v... | |||||||||||||
Medical condition: Verbesserung der gastrointestinalen Verträglichkeit einer per-oralen Antibiotikatherapie | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001169-18 | Sponsor Protocol Number: UoL001360 | Start Date*: 2018-10-15 | ||||||||||||||||
Sponsor Name:University Of Liverpool | ||||||||||||||||||
Full Title: The efficacy and mechanism of surfactant therapy for critically ill infants with bronchiolitis: The Bronchiolitis Endotracheal Surfactant Study. | ||||||||||||||||||
Medical condition: Critical Illness due to Bronchiolitis of infancy requiring conventional invasive Mechanical Ventilation (MV) Diagnosis of bronchiolitis per clinical criteria defined in national guidance NICE-NG9. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001113-21 | Sponsor Protocol Number: NDPHRECOVERY | Start Date*: 2020-03-17 | ||||||||||||||||
Sponsor Name:University of Oxford | ||||||||||||||||||
Full Title: Randomised Evaluation of COVID-19 Therapy (RECOVERY) | ||||||||||||||||||
Medical condition: COVID-19 (infection with SARS-CoV-2 virus) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016731-34 | Sponsor Protocol Number: CRO1413 | Start Date*: 2010-01-08 | |||||||||||
Sponsor Name:Imperial College | |||||||||||||
Full Title: Amino acid regimen and intravenous lipid composition in preterm parenteral nutrition: a randomised double blind controlled trial of Nutritional Evaluation and Optimisation in Neonates. | |||||||||||||
Medical condition: Preterm birth | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002345-39 | Sponsor Protocol Number: Göteborg University | Start Date*: 2006-02-16 |
Sponsor Name:NOPHO NHL-group | ||
Full Title: B-NHL BFM 04 | ||
Medical condition: B-cell lymphoma or B-ALL in children up to 18 years of age | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002198-44 | Sponsor Protocol Number: P903-21 | Start Date*: 2011-07-22 | |||||||||||
Sponsor Name:Cerexa, Inc. (subsidary of Forest Laboratories) | |||||||||||||
Full Title: Pharmacokinetics of a Single Dose of Ceftaroline fosamil in Children Ages Birth to Younger Than 12 Years With Suspected or Confirmed Infection | |||||||||||||
Medical condition: Pharmacokinetics of a Single Dose of Ceftaroline fosamil in Children Ages Birth to Younger Than 12 Years With Suspected or Confirmed Infection | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021295-28 | Sponsor Protocol Number: ottavi | Start Date*: 2010-09-30 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA | |||||||||||||
Full Title: therapy antiedemigena through administration of corticosteroidi after surgical extraction of the teeth of the judgment. | |||||||||||||
Medical condition: This study is going to be performed on patients afferent to the service of Chirurgia Maxillo Facciale dell’Ospedale Maggiore della Carita` di Novara subject to eights bony included extraction. | |||||||||||||
|
|||||||||||||
Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005497-28 | Sponsor Protocol Number: PedMic | Start Date*: 2013-09-27 |
Sponsor Name:Erasmus MC - Sophia | ||
Full Title: Pediatric Microdosing: elucidating age-related changes in oral absorption | ||
Medical condition: Age-related changes in intestinal drug metabolism in children | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2009-014892-31 | Sponsor Protocol Number: MAIVECMOPAIN | Start Date*: 2009-11-10 |
Sponsor Name:ErasmusMC - Sophia | ||
Full Title: Morphine intravenous vs. Paracetamol intravenous in children on ECMO | ||
Medical condition: Patients treated with Extra Corporal Membrane Oxygenation (ECMO) receive morphine as standardised analgesic drug. Morphine is associated with several side effects. In these patients a non-opioid dr... | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001996-13 | Sponsor Protocol Number: Tirofiban-Urokinasi 2007 | Start Date*: 2007-06-06 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA SENESE | |||||||||||||
Full Title: Intravenous glycoprotein IIbIIIa inhibitor (Tirofiban) combined with low dose of intra-arterial Urokinase for the endovascolar treatment of patients with acute major ischemic stroke | |||||||||||||
Medical condition: patients with major ischemic stroke not suitable for other authorized treatment for riperfusion of the ischemic area | |||||||||||||
|
|||||||||||||
Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001569-16 | Sponsor Protocol Number: VITPED/P01/04/MU.UK | Start Date*: 2006-07-17 |
Sponsor Name:BAXTER SAS R&D Parenteral Nutrition | ||
Full Title: EFFICIENCY AND SAFETY OF CLINAVIT PAEDIATRIC AT A WEIGHT DEPENDANT DOSE ADMINISTERED DAILY FOR 5 CONTINUOUS DAYS ON 4 VITAMINS BLOOD LEVEL IN NEONATES AND CHILDREN UP TO 11 YEARS OF AGE RECEIVING P... | ||
Medical condition: No special medical condition but Patient requiring for any underlying pathology at least 5 days of total parenteral nutrition, representing at least 90% of their total energy needs | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003781-42 | Sponsor Protocol Number: 17465 | Start Date*: 2005-09-21 |
Sponsor Name:University of Dundee | ||
Full Title: | ||
Medical condition: Transient hypothyroxinanaemia | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-024387-17 | Sponsor Protocol Number: CPI-CL-012 | Start Date*: 2012-05-16 |
Sponsor Name:Cumberland Pharmaceuticals Inc. | ||
Full Title: A Multi-center, Randomized, Open-Label, Parallel, Active-Comparator, Multiple Dose Trial to Determine the Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Pediatric Patients | ||
Medical condition: fever | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: PL (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
